Clinical Trials Early Career Investigator Showcase

New submission category at CTAD: 15. Clinical Trials Early Career Investigator Showcase

Early career investigators on a career track as an AD/ADRD therapeutic trials clinical investigator or principal investigator play a critical role in the advancement of AD/ADRD therapeutic research through new discoveries, improved methodologies, and translation of successful interventions into clinical care. These individuals will also design and lead the next generation of AD/ADRD clinical trials, build the global trials network and form the next generation of investigators and clinical trials leaders in the field.

Promoting the professional development of these emerging leaders is vital for their success. CTAD is the only conference that brings together the world’s leading AD/ADRD clinical trialists working in academia, industry and not-for-profit organizations and has a focus on Alzheimer’s Disease therapeutic trials. A platform at CTAD for these early-career investigators to showcase their research will increase their visibility and support their professional advancement. Such a space also gives them the opportunity to converse with senior clinical trialists about their work, learn about potential research opportunities early in their career, and help establish a global early career trials investigator network.

Submission criteria for this category:

  • Individuals can be from academia, industry, or not for profit organizations.
  • Research projects must have direct relevance to AD/ADRD clinical trials design, conduct or analysis.
  • Must be AD/ADRD clinical trials research (only human trials) including but not limited to the areas of study design, biomarkers (imaging, biofluids, digital) outcomes, clinical/functional outcomes, recruitment and retention science, trials operations, statistical methodology and regulatory science.
  • Individuals must be within 7 years of completing a terminal degree (e.g. MD, PhD, PharmD) 

This category is only for POSTER submissions - Poster Session: A featured poster session at CTAD24 will highlight relevant and impactful research being conducted in the field of AD/ADRD clinical trials research.  

Please note that if the Scientific Committee feels that your abstract is not a good fit for this category, you will be redirected to another submission topic.